One billion people currently suffer from neurological disorders, and current treatments neglect the ways in which an individual’s physiology and health history affect their cognition. As the personalized medicine industry grows, neural interfaces will change the way scientists observe and treat illnesses.

Neurotech will revolutionize the treatment of neurological disorders, and even adult-onset diseases. Faith Inello will share her experience as a 15-year-old who is developing non-invasive treatment options for neurological conditions, based on her research in adverse childhood experiences and synaptic plasticity. She will also discuss the ethical and societal implications of manipulating the brain, and neurotechnology’s scalability.